Press "Enter" to skip to content

New patent for Cubist Pharms drug ZERBAXA

0
Copyright © DrugPatentWatch. Originally published at New patent for Cubist Pharms drug ZERBAXA

Annual Drug Patent Expirations for ZERBAXA
Annual Drug Patent Expirations for ZERBAXA

Zerbaxa is a drug marketed by Cubist Pharms Llc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.

This drug has eigthy-six patent family members in thirty-one countries.

The generic ingredient in ZERBAXA is ceftolozane sulfate; tazobactam sodium. One supplier is listed for this compound. Additional details are available on the ceftolozane sulfate; tazobactam sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Cubist Pharms drug ZERBAXA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions